3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Prostatic Neoplasms
112
Breast Neoplasms
17
Neoplasms
7
Leiomyoma
6
Prostate Adenocarcinoma
3
Polycystic Ovary Syndrome
3
Salivary Gland Neoplasms
2
Neoplasm Metastasis
2
Multiple Myeloma
2
Lymphoma, Non-Hodgkin
2
Uveal Melanoma
1
Stage I Prostate Adenocarcinoma AJCC v7
1
Sleep Apnea, Obstructive
1
Skin Neoplasms
1
Sexual Dysfunctions, Psychological
1
Sexual Dysfunction, Physiological
1
Salivary Gland Neoplasm Duct
1
Recurrence
1
Puberty, Precocious
1
Primary Dysautonomias
1
Premenopausal Breast Cancer
1
Patient Compliance
1
PSA Level Greater Than Two
1
Obesity, Morbid
1
Obesity
1
Myofibroma
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Metabolic Syndrome
1
Melanoma
1
Interventions
Exercise
24
Metformin
19
Tirzepatide
9
Resistance Training
8
Nutrition Assessment
8
Methods
8
Diet Therapy
8
Diet
8
Counseling
7
Surveys and Questionnaires
6
semaglutide
5
Liraglutide
5
Exenatide
5
Early Intervention, Educational
5
Diet, Mediterranean
5
Caloric Restriction
5
Blood Specimen Collection
5
Educational Status
4
Bariatric Surgery
4
Vitamin D
3
Sugars
3
Standard of Care
3
Naltrexone
3
Letrozole
3
Docosahexaenoic Acids
3
Dexamethasone
3
Bupropion
3
exemestane
2
bupropion hydrochloride, naltrexone hydrochoride drug combination
2
Yoga
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Obesity
×
Leuprolide
×
Clear all
NCT01422096
2018-07-19
CBS007
University of Virginia
Phase EARLY_PHASE1
Withdrawn